Metformin treatment (≥10 mM) staunchly reduced HES1 expression, which is regulated by Notch, Wnt, or Hedgehog signaling, so this alteration in gene expression could be an important moderator of NSCLC [29]. The gene discussed is HES1; the disease is non-small cell lung carcinoma.